Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
Locations
1
United States
St. Jude Children's Research Hospital
Memphis, Tennessee, United States
Start Date
October 29, 2007
Primary Completion Date
September 26, 2020
Completion Date
March 26, 2022
Last Updated
August 23, 2022
NCT06735690
NCT06074666
NCT04972942
NCT06395103
NCT07523555
NCT07295951
Lead Sponsor
St. Jude Children's Research Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions